Abstract
Abstract
Background
COVID-19 is a highly contagious disease where isolation of infected individuals is deemed warranted. If possible, home isolation is preferred over hospitalization. This implies a need for methods of observation that can ensure the safety of these patients. Preventive treatment methods that can both decrease the probability for development of critical disease and hopefully decrease the need for hospitalization would be an added benefit. This was a single-arm prospective pilot study performed to assess the feasibility of performing self-measurements of SpO2 and respiratory exercises in at-home isolated COVID-19 patients.
Method
A total of 40 ambulant SARS-CoV-2-positive individuals in home isolation were followed up for a period of 14 days. At baseline, they were equipped with a pulse oximeter, PEF meter, a project diary to note all measurements, and simple instructions on how to perform respiratory exercises. No other contact was made, but participants were instructed to contact the hospital based on given criteria for blood oxygenation levels and dyspnea severity and to return study equipment and the project diary at the end of study.
Results
During the follow-up period, 35 participants (87.5%) recorded daily SpO2 measurements, and 12 (30%) adhered to daily respiratory exercises as instructed. Four participants (10%) were admitted to hospital during the follow-up period. Five participants terminated follow-up prematurely.
Conclusions
Performing self-measurements of SpO2 during home isolation due to COVID-19 infection is feasible. The feasibility of performing respiratory exercises in ambulant patients is questionable and may require more motivational interventions to increase adherence.
Trial registration
ClinicalTrials.gov identifier: NCT04647747.
Publisher
Springer Science and Business Media LLC
Reference22 articles.
1. Novel coronavirus pneumonia emergency response epidemiology team. Vital surveillances: the epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) – China. China CDC Weekly. 2020;2(8):113–22.
2. Li J, Huang DQ, Zou B, Yang H, Hui WZ, Rui F, et al. Epidemiology of COVID-19: a systematic review and meta-analysis of clinical characteristics, risk factors, and outcomes. J Med Virol. 2021;93(3):1449–58.
3. Norwegian Institute of Public Health. COVID-19 Ukerapport – uke 8 [press release]. Oslo: Norwegian Institute of Pulic Health; 2021.
4. World Health Organization. Weekly epidemiological update on COVID-19 2023. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20230413_weekly_epi_update_138.pdf. Cited 2023 Apr 13.
5. Health TNDo. Testing, symptoms and infection control 2021. Available from: https://www.helsenorge.no/en/coronavirus/testing-symptoms-and-close-contacts/. Accessed 31 May 2022.